Brief: Onxeo Appoints Dr. Shefali Agarwal As CEO

Valerio Therapeutics SA

07/04/2022 06:12

April 7 (Reuters) - Onxeo SA  ALONX.PA :
    * ONXEO APPOINTS DR. SHEFALI AGARWAL AS PRESIDENT AND CHIEF
EXECUTIVE OFFICER
    * DR. AGARWAL SUCCEEDS JULIEN MIARA, A PRINCIPAL AT INVUS
SAS, WHO
WAS NAMED INTERIM CEO IN JANUARY 2022
    * COMPANY OUTLINES DEVELOPMENT STRATEGY PLANS INCLUDING
PREPARATION FOR U.S. PRE-IND MEETING FOR FIRST-IN-CLASS DDR
INHIBITOR ASIDNA AND PLANS FOR BUILDING INFRASTRUCTURE IN UNITED
STATES
    * NEW PRIVATE FINANCING EXPANDS ONXEO'S RUNWAY INTO Q2 2023
    * NEW INFLUX OF CAPITAL FROM OUR TOP TWO SHAREHOLDERS, WHO
SUPPORT
OUR VISION, WILL HELP US ACHIEVE OUR GOALS, PROVIDING ONXEO
RUNWAY INTO Q2 2023-CEO

Source text for Eikon:  ID:nBw5d4z9Na 
Further company coverage:  ALONX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))